<DOC>
	<DOC>NCT00370240</DOC>
	<brief_summary>The aim of the study is to evaluate the effect of local anesthetic (chlorhydrate of ropivacaine) to prevent chronic pain after breast surgery for cancer.</brief_summary>
	<brief_title>Chlorhydrate of Ropivacaine and Breast Cancer Surgery</brief_title>
	<detailed_description>An estimated 20-65% of women treated with breast surgery for breast cancer experience chronic pain in the treated breast. Patients will be randomize between: infiltration with chlorhydrate of ropivacaine at the time of breast surgery for cancer versus placebo.Intra-operative analgesia will be standardized as well as peri-operative pain management.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>Breast cancer patients treated by conservative surgery with axillary node dissection or treated by mastectomy with or without axillary node dissection or sentinel lymph node biopsy. ASA physical status 1, 2 or 3 With a minimum life expectancy of 2 years Written informed consent Any previous cancer other than breast cancer Allergies to local anesthesic and morphine Reported history of drug Pregnancy Homolateral breast surgery during the last 3 years Analgesic use preoperatively Renal, pulmonary or liver major dysfunction Active malignant disease Unable to follow the protocol for any reason</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2007</verification_date>
	<keyword>Female</keyword>
	<keyword>Anesthetics,local</keyword>
</DOC>